drugset / Trial / NCT07845578

A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight

NCT07845578 ↗

Phase 1 Not yet recruiting 60 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to determine the effect of semaglutide on gastric emptying in people with obesity. Participants will receive either semaglutide or placebo, and the treatment assigned will be decided by chance. Semaglutide is a medicine that doctors can already prescribe, while placebo contains no active medicine.

Timeline

Start
2026-09-25
Primary completion
2027-09-11
Completion
2027-09-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — Oral
Subject Semaglutide Peptide — Subcutaneous

Indications